Glint Pharmaceuticals to Present at OIS/SECO 2023 Ophthalmology Conference
UF startup Glint Pharmaceuticals will present its drug releasing contact lens technology at the OIS SECO 2023 ophthalmology conference, in Atlanta on March 1. OIS SECO is a leading ophthalmology conference where industry leaders and optometrists meet to present innovative technologies and clinical results.
The first Glint product, MoxiLens™, is an antibiotic-releasing contact lens. The target market for an effective and convenient treatment for corneal infection and injury includes more than 10 million patients in the US and EU. The current standard of care requires the patient to administer antibiotic eye drops on a frequent basis over several days to treat the ocular infection. The Glint lens will eliminate the need for most patients to use antibiotic eye drops. Replacing the need for patients to apply eye drops will increase compliance and may lead to better therapeutic outcomes.Read more about Glint Pharmaceuticals to Present at OIS/SECO 2023 Ophthalmology Conference.